Daunorubicin Citrate is an anthracycline antibiotic chemotherapy medication primarily indicated for the treatment of acute myeloid leukemia, acute lymphoblastic leukemia, and various solid tumors. By intercalating… Read more
Daunorubicin Citrate is an anthracycline antibiotic chemotherapy medication primarily indicated for the treatment of acute myeloid leukemia, acute lymphoblastic leukemia, and various solid tumors. By intercalating into DNA and inhibiting topoisomerase II, the drug effectively disrupts the growth and replication of cancer cells. This category provides access to high-quality reference standards for Daunorubicin Citrate API, as well as its related impurities, metabolites, and stable isotope labelled compounds. Pharmaceutical laboratories rely on these materials for critical applications such as impurity profiling, method validation, and routine quality control processes. By utilizing these characterized compounds, analytical chemists can accurately identify and quantify degradation products and metabolites, ensuring compliance with regulatory requirements throughout the drug development and manufacturing lifecycle.